Peter is a trial lawyer and co-chair of the firm's Global Life Sciences Practice. While Peter focuses his practice on patent infringement actions regarding pharmaceuticals, medical devices, and biotechnology, he has served as lead counsel for both plaintiffs and defendants in a wide range of matters in Federal courts across the country and in national and international arbitrations.
As lead counsel representing defendants, Peter has defeated over $1 billion in damages claims at trial or arbitration, and defeated another over $1 billion in damages claims on summary judgment or as a result of other pre-trial procedures. As lead counsel representing plaintiffs, Peter has protected over $10 billion in sales for his branded pharmaceutical clients and won jury trial damages for his medical device clients.
Managing Intellectual Property magazine has named Peter one of "America's Best Life Sciences Litigators," including him in its Top 10 list for 2012. The LMG Life Sciences 2012 rankings echo this praise, listing Peter as a top performer.
Peter has been recognized by Chambers USA as a leading lawyer in intellectual property every year since 2007. Chambers has noted in various years that Peter is a "strong leader and trial lawyer" who is "tremendously strategic in setting up a case" and has a "track record of winning."
Peter has also been listed in a number of other guides and rankings, including the IAM Life Sciences 250 and the IAM Patent Litigation 250. IAM has reported client comments that "he is one of the smartest lawyers out there and handles cases expertly and efficiently, obtaining great results at a reasonable cost – often through facilitating early wins."